New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development

Antimicrob Agents Chemother. 2009 Mar;53(3):849-62. doi: 10.1128/AAC.00749-08. Epub 2008 Dec 15.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antitubercular Agents / pharmacokinetics*
  • Antitubercular Agents / pharmacology*
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Design*
  • Drug Evaluation, Preclinical
  • Drug Resistance, Bacterial
  • Fluoroquinolones / adverse effects
  • Humans
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics
  • Rifamycins / pharmacokinetics
  • Rifamycins / pharmacology
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology
  • Tuberculosis / therapy*

Substances

  • Antitubercular Agents
  • Fluoroquinolones
  • Rifamycins